Abstract
The prevalence of allergy and asthma has been increasing steadily in the developed world. Despite the growing health problems associated with these conditions few new therapeutic options are becoming available. Relatively recent developments have identified a role for proteases in promoting allergic sensitisation and allergic airway inflammation. It is also known that most major allergens have associated protease activity that is closely related to their efficacy to induce sensitization and inflammation. Here we review the evidence for the significance of protease activity in allergic airway disease and offer suggestions as to where the field could progress.
Keywords: Asthma, allergen, serine proteases, protease-activated receptors, allergic inflammation
Inflammation & Allergy - Drug Targets (Discontinued)
Title: Should we Target Allergen Protease Activity to Decrease the Burden of Allergic Airway Inflammation?
Volume: 7 Issue: 4
Author(s): Harissios Vliagoftis and Paul Forsythe
Affiliation:
Keywords: Asthma, allergen, serine proteases, protease-activated receptors, allergic inflammation
Abstract: The prevalence of allergy and asthma has been increasing steadily in the developed world. Despite the growing health problems associated with these conditions few new therapeutic options are becoming available. Relatively recent developments have identified a role for proteases in promoting allergic sensitisation and allergic airway inflammation. It is also known that most major allergens have associated protease activity that is closely related to their efficacy to induce sensitization and inflammation. Here we review the evidence for the significance of protease activity in allergic airway disease and offer suggestions as to where the field could progress.
Export Options
About this article
Cite this article as:
Vliagoftis Harissios and Forsythe Paul, Should we Target Allergen Protease Activity to Decrease the Burden of Allergic Airway Inflammation?, Inflammation & Allergy - Drug Targets (Discontinued) 2008; 7 (4) . https://dx.doi.org/10.2174/187152808786848379
DOI https://dx.doi.org/10.2174/187152808786848379 |
Print ISSN 1871-5281 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4055 |
Related Articles
-
Role of IL-17F in the Pathogenesis of Psoriasis
Current Immunology Reviews (Discontinued) Data Science Approaches to Pharmacogenetics
Current Molecular Medicine Modulation of the Fce Receptor I Signaling by Tyrosine Kinase Inhibitors: Search for Therapeutic Targets of Inflammatory and Allergy Diseases
Current Pharmaceutical Design PUFA for Human Health: Diet or Supplementation?
Current Pharmaceutical Design Investigation of Family 18 Chitinases and Inhibitors by Computer-Aided Approaches
Current Drug Targets Gene Therapy and Targeted Toxins for Glioma
Current Gene Therapy Liposomes for Pulmonary Drug Delivery: The Role of Formulation and Inhalation Device Design
Current Pharmaceutical Design Chronic Diseases and COVID-19: A Review
Endocrine, Metabolic & Immune Disorders - Drug Targets Modulating Co-Stimulation During Antigen Presentation to Enhance Cancer Immunotherapy
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Recent Advances in the Characterization of Genetic Factors Involved in Human Susceptibility to Infection by Schistosomiasis
Current Genomics Resveratrol and Clinical Trials: The Crossroad from In Vitro Studies to Human Evidence
Current Pharmaceutical Design Mechanisms of HIV Neuropathogenesis: Role of Cellular Communication Systems
Current HIV Research Clinical Thiazolidinediones as PPARγ Ligands with the Potential for the Prevention of Cardiovascular Disease in Diabetes
Current Diabetes Reviews A Knock-Down Cell-Based Study for the Functional Analysis of Chloride Intracellular Channel 1 (CLIC1): Integrated Proteomics and Microarray Study
Protein & Peptide Letters Contribution of Efflux Pump Activity to the Delivery of Pulmonary Therapeutics
Current Drug Metabolism Novel Applications of Recombinant Lactic Acid Bacteria in Therapy and in Metabolic Engineering
Recent Patents on Biotechnology Gene Therapy Targeting Nuclear Factor-κB: Towards Clinical Application in Inflammatory Diseases and Cancer
Current Gene Therapy Challenges in the Management of Severe Asthma: Role of Current and Future Therapies
Current Pharmaceutical Design Therapeutic Potential of microRNA Against Th2-associated Immune Disorders
Current Topics in Medicinal Chemistry Regulation of Electrolyte Permeability by Herbal Monomers in Edematous Disorders
Current Pharmaceutical Design